MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$125,424K
Free Cash flow
-$164,174K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Maturities of investments
Proceeds from issuance of common...
Others
Negative Cash Flow Breakdown
Purchases of investments
Net loss
Proceeds from rpi transactions
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-198,762
-206,031
-183,031
-306,178
Non-cash interest expense on liabilities related to revenue participation right purchase agreements
20,177
18,816
16,061
14,995
Stock-based compensation expense
35,711
30,394
30,506
30,696
Non-cash lease expense
1,625
1,585
1,610
1,472
Loss on disposition of property and equipment
-
-
0
-
Depreciation of property and equipment
3,631
3,378
2,861
2,679
Change in fair value of derivative liabilities
-1,100
1,500
900
700
Change in fair value of liabilities related to rpi transactions
2,400
-1,600
13,300
-2,800
Realized gain on investment, net
60
61
8
1
Interest receivable and amortization on investments
-4,352
-1,874
-3,075
-2,696
Non-cash interest expense related to debt
8,731
8,455
8,470
5,648
Debt conversion expense
-
-
0
121,249
Accounts receivable
17,605
-10,937
15,956
-6,602
Prepaid and other assets
4,843
-2,057
4,197
-6,277
Inventories
2,256
3,567
-
-
Accounts payable
30
1,519
-309
6,598
Deferred revenue
0
41
0
268
Accrued and other liabilities
5,247
-6,213
26,368
7,617
Operating lease liabilities
-2,703
-1,039
-4,223
-2,150
Other non-current liabilities
-3,111
-3,954
-3,528
-2,681
Net cash used in operating activities
-159,840
-145,457
-142,651
-107,505
Purchases of investments
727,265
106,516
345,650
335,452
Investment in non-marketable equity security
0
0
0
0
Maturities of investments
224,601
257,938
280,094
273,826
Sales of investments
0
-
8
1
Purchases of property and equipment
4,334
5,930
5,644
9,354
Net cash (used in) provided by investing activities
-506,998
145,492
-71,192
-70,979
Repayment of finance lease liabilities
0
0
0
0
Repayment of term loans
3,594
2,735
2,722
2,709
Repayment of convertible debt
-
-
0
402,500
Proceeds from issuance of convertible debt, net
-
-
0
729,460
Payments of royalty obligations
-214
-
-
-
Proceeds from rpi transactions
-75,000
-
-
0
Proceeds from draw on rpi multi tranche loan
-
-
175,000
-
Proceeds from issuance of common stock related to at-the-market offering, net of issuance costs-At The Market Offering
-
-
0
0
Proceeds from issuance of common stock related to at-the-market offering, net of issuance costs-Public Offering
-
-
0
0
Proceeds from issuance of common stock related to private placement, net of issuance costs
-
-
0
0
Proceeds from issuance of common stock related to at-the-market offering, net of issuance costs
760,149
-
-
-
Proceeds from issuance of common stock under equity incentive and stock purchase plans
38,002
11,346
14,648
6,935
Taxes paid related to net share settlement of equity awards
1,486
841
1,221
720
Net cash provided by financing activities
792,857
7,770
110,705
330,466
Effect of exchange rate changes on cash
-595
-483
191
46
Net (decrease) increase in cash, cash equivalents, and restricted cash
125,424
7,322
-102,947
152,028
Cash, cash equivalents, and restricted cash, beginning of period
132,954
125,632
74,055
74,055
Cash, cash equivalents, and restricted cash, end of period
258,378
132,954
125,632
228,579
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock related to...
$760,149K
something is missing
$75,000K
Proceeds from issuance of
common stock under...
$38,002K
(463.41%↑ Y/Y)
Net cash provided by
financing activities
$792,857K
(909.58%↑ Y/Y)
Canceled cashflow
$80,294K
Net (decrease)
increase in cash, cash...
$125,424K
(4925.00%↑ Y/Y)
Canceled cashflow
$667,433K
Proceeds from rpi
transactions
-$75,000K
(-200.00%↓ Y/Y)
Repayment of term loans
$3,594K
(33.31%↑ Y/Y)
Taxes paid related to
net share...
$1,486K
(189.11%↑ Y/Y)
Payments of royalty
obligations
-$214K
Maturities of investments
$224,601K
(-18.03%↓ Y/Y)
Stock-based compensation
expense
$35,711K
(29.69%↑ Y/Y)
Non-cash interest
expense on liabilities...
$20,177K
(52.78%↑ Y/Y)
Non-cash interest
expense related to debt
$8,731K
(63.81%↑ Y/Y)
Accrued and other
liabilities
$5,247K
(-62.48%↓ Y/Y)
Depreciation of property and
equipment
$3,631K
(58.91%↑ Y/Y)
Non-cash lease expense
$1,625K
(21.63%↑ Y/Y)
Change in fair value of
derivative liabilities
-$1,100K
(-136.67%↓ Y/Y)
Accounts payable
$30K
(-96.84%↓ Y/Y)
Net cash (used in)
provided by investing...
-$506,998K
(-1058.75%↓ Y/Y)
Net cash used in
operating activities
-$159,840K
(-24.65%↓ Y/Y)
Effect of exchange rate
changes on cash
-$595K
(12.76%↑ Y/Y)
Canceled cashflow
$224,601K
Canceled cashflow
$76,252K
Purchases of investments
$727,265K
(226.18%↑ Y/Y)
Net loss
-$198,762K
(-47.92%↓ Y/Y)
Purchases of property and
equipment
$4,334K
(4.56%↑ Y/Y)
Accounts receivable
$17,605K
(175.16%↑ Y/Y)
Prepaid and other assets
$4,843K
(4.44%↑ Y/Y)
Interest receivable and
amortization on investments
-$4,352K
(-7.94%↓ Y/Y)
Other non-current
liabilities
-$3,111K
(-87.18%↓ Y/Y)
Operating lease
liabilities
-$2,703K
(-16.36%↓ Y/Y)
Change in fair value of
liabilities related to rpi...
$2,400K
(116.44%↑ Y/Y)
Inventories
$2,256K
Realized gain on
investment, net
$60K
(275.00%↑ Y/Y)
Buy us a coffee
CYTK_BIG
CYTOKINETICS INC (CYTK)
CYTK_BIG
CYTOKINETICS INC (CYTK)